International Journal of Clinical Pharmacy

, Volume 33, Issue 1, pp 88–91

A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment

Research Article

Abstract

Objective A major UK Pharmacy chain private Chlamydia screening and treatment service began in October 2006. People pay for a screening kit, send off a urine sample, and are informed of their result directly. Treatment is accessed via the pharmacy chain or the National Health Service. We analysed data from the first 2 years of the service to describe the positivity rate by age and gender, profile of users and to determine if the program succeeded in reaching those who are currently being missed in other clinical settings. Setting Three hundred and thirty-eight community pharmacies from a major pharmacy chain in England and Wales. Methods Cross sectional study of the first 2 years screening and treatment data. Data was collected on number of tests, test results, age and gender. Data was also collected on treatment uptake by age and gender. Further Data regarding the treatment service including the site, was collected on customer record forms. Positivity data was analysed using χ2. Results A total of 14,378 private Chlamydia screening tests were performed in pharmacies during the 2 year period. Overall positivity rates in males (9.8%) were higher than females (6.8%). The positivity rate was significantly higher in the 16–24 age group than in the 25 and over age group. A total of 533 people accessed and paid for treatment from Boots out of a total of 1,131 people who tested positive (47.1%). Hundred and thirty three (25.0%) partners also accessed treatment. Conclusions The data further supports the feasibility and acceptability of pharmacy testing and treatment.

Keywords

Chlamydiatrachomatis Partner tracing Pharmacy practice Screening UK 

References

  1. 1.
    New frontiers: annual report of the National Chlamydia Screening Programme in England. London: Health Protection Agency.http://www.chlamydiascreening.nhs.uk/ps/publications/index.html (2005/06). Accessed 28 Oct 2010.
  2. 2.
    Cates W, Wasserheit JN. Genital Chlamydia infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol. 1991;164:1771–81.PubMedGoogle Scholar
  3. 3.
    Risser WL, Risser JMH. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review. Int J STD AIDS. 2007;18:727–31.PubMedCrossRefGoogle Scholar
  4. 4.
    National Chlamydia Screening Programme http://www.chlamydiascreening.nhs.uk/. Accessed 28 Oct 2010.
  5. 5.
    Choosing Health through Pharmacy. Crown Copyright 2005. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4107494. Accessed 28 Oct 2010.
  6. 6.
    Respect and responsibility: strategy and action plan for improving sexual health’ Scottish Executive, Edinburgh, 2005. ISBN: 0-7559-4387-2 http://www.scotland.gov.uk/Publications/2005/01/20603/51182. Accessed 28 Oct 2010.
  7. 7.
    Anderson C, Blenkinsopp A. Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence. Hum Repr. 2006;21:272–8.CrossRefGoogle Scholar
  8. 8.
    Editorial. Chlamydia—a testing issue Lancet 2005 365:630.Google Scholar
  9. 9.
    Van Bergen JEAM, Postma MJ, Peerbooms PGH, et al. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples. Int J STD AIDS. 2004;15:797–802.PubMedCrossRefGoogle Scholar
  10. 10.
    Baraitser P, Pearce V, Holmes J, Horne N, Boynton PM. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London. Qual Saf Health Care. 2007;16:303–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Healthcare TNS. Pharmacy Chlamydia Screening Pathfinder Evaluation (PCSPf) final. London: Department of Health; 2007.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Division of Social Research in Medicines and Health, School of PharmacyUniversity of NottinghamNottinghamUK
  2. 2.Department of Research and DevelopmentBoots UKNottinghamUK

Personalised recommendations